Though much of the health community has been focused on a vaccine for the novel coronavirus, doctors have started eagerly hailing a new children’s drug as a potential cure for severe cases of the disease.
According to The Daily Mail, the drug in question is called ruxolitinib and is used to treat a potentially fatal auto-immune disease in children known Hemophagocytic Lymphohistiocytosis (HLH). The medication essentially works by calming down the immune system and stopping it from going into overdrive.
However, though the medication might be intended for children, scientists from Cincinnati Children’s Hospital in Ohio have claimed that patients who received ruxolitinib were 10 times more likely to have significant improvements in their respiratory symptoms.
The doctors first suggested a trial with the drug when they realized that one of the most severe complications of COVID-19 was known as a cytokine storm — which is is also a symptom of HLH.
0 comments :
Post a Comment